Huang, Huimin
Luo, Wenting
Wei, Nili
Liang, Xueqing
Zheng, Peiyan
Hu, Haisheng
Sun, Baoqing http://orcid.org/0000-0002-1671-0723
Funding for this research was provided by:
Medical Science and Technology Research Foundation of Guangdong (A2019224)
Guangzhou Education Bureau (1201630393; 1201630044)
National Natural Science Foundation of China (81871736, 81802076, 81601394)
Cultivation Project of the First Affiliated Hospital of Guangzhou Medical University (ZH201818)
Article History
Received: 9 September 2019
Accepted: 11 February 2020
First Online: 24 February 2020
Ethics approval and consent to participate
: The study was approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University (Ethical code: GYFYY-2016-73). Serum samples were collected from the Respiratory Diseases Bioresources Center of the National Center for Respiratory Diseases in southern China. All patients had signed the formal written informed consent before their biological samples were entered into the biological resource database. The Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University approved that when using the biological samples from the Respiratory Diseases Bioresources Center of the National Center for Respiratory Diseases, it was only necessary to inform the patients or the parents/guardians of the patients orally. In this study, oral consent was obtained from parents/guardians of the children to participate after they had filled the questionnaires, and then detected serum ALA-, BLG-, and CAS-sIgE of the children.
: Not applicable.
: The authors declare that they have no competing interests.